The use of Lipid Based Formulations (LBFs) can improve the solubilization of lipophilic poorly water-soluble drugs in the gastrointestinal tract. This method avoids solid-state limitations as the drug is solubilized at the site of absorption. However, one major disadvantage of this approach is that only a limited number of molecules can achieve adequate drug loading in lipid vehicles.